Evidence map›Paper›PMID 29949960›Full record

ArticleBioinformatics (Oxford, England)2018

aliFreeFold: an alignment-free approach to predict secondary structure from homologous RNA sequences.

Jean-Pierre Séhi Glouzon, Aïda Ouangraoua

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jean-Pierre Séhi GlouzonDepartment of Computer Science, University of Sherbrooke, Sherbrooke, QC, Canada.
Aïda OuangraouaDepartment of Computer Science, University of Sherbrooke, Sherbrooke, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Predicting the conserved secondary structure of homologous ribonucleic acid (RNA) sequences is crucial for understanding RNA functions. However, fast and accurate RNA structure prediction is challenging, especially when the number and the divergence of homologous RNA increases. To address this challenge, we propose aliFreeFold, based on a novel alignment-free approach which computes a representative structure from a set of homologous RNA sequences using sub-optimal secondary structures generated for each sequence. It is based on a vector representation of sub-optimal structures capturing structure conservation signals by weighting structural motifs according to their conservation across the sub-optimal structures. Results: We demonstrate that aliFreeFold provides a good balance between speed and accuracy regarding predictions of representative structures for sets of homologous RNA compared to traditional methods based on sequence and structure alignment. We show that aliFreeFold is capable of uncovering conserved structural features fastly and effectively thanks to its weighting scheme that gives more (resp. less) importance to common (resp. uncommon) structural motifs. The weighting scheme is also shown to be capable of capturing conservation signal as the number of homologous RNA increases. These results demonstrate the ability of aliFreefold to efficiently and accurately provide interesting structural representatives of RNA families. Availability and implementation: aliFreeFold was implemented in C++. Source code and Linux binary are freely available at https://github.com/UdeS-CoBIUS/aliFreeFold. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

SoftwareAlgorithmsNucleic Acid ConformationRNASequence Analysis, RNARNA

Identifiers

PMID29949960
PMCPMC6022685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.